Vanguard Capital Management
TELA icon

Vanguard Capital Management’s TELA Bio TELA Stock Holding History

Vanguard Capital Management’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18M Buy
1,568,218
+27,594
+2% +$22.6K ﹤0.01% 3562
2026
Q1 		$955K Buy
+1,540,624
New +$1.34M ﹤0.01% 3563

Other funds holding TELA

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3B AUM 119.43% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
WA
WealthTrust Axiom Wayne, Pennsylvania $448M AUM 50.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Vanguard Capital Management's TELA Position: Q2 2026 in Review

Vanguard Capital Management increased its TELA Bio (TELA) stake by 1.8% in Q2 2026, buying an estimated $22.6K and bringing the position to 1,568,218 shares worth $1.18M. The position accounts for ﹤0.01% of the portfolio, ranked #3562.

Vanguard Capital Management first reported a position in TELA in Q1 2026 and has held it in 2 quarters since. 44 funds tracked by Wall St. Rank hold TELA as of Q2 2026.

  • Vanguard Capital Management held 1,568,218 shares of TELA Bio worth $1.18M as of Q2 2026.
  • Vanguard Capital Management bought 27,594 TELA Bio shares in Q2 2026, an estimated $22.6K.
  • TELA Bio made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3562 holding.
  • Vanguard Capital Management first reported a position in TELA Bio in Q1 2026 and has held it in 2 quarters since.
  • 44 funds tracked by Wall St. Rank held TELA Bio as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.